Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi V Dang

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
Cell Metabolism|March 7, 2006
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxiaJung-whan Kim, Irina Tchernyshyov, Gregg L Semenza, et al.
Trends in Cancer|September 5, 2021
Tilting MYC toward cancer cell deathColleen T Harrington, Elena Sotillo, Chi V Dang, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 9, 2011
Therapeutic targeting of cancer cell metabolismChi V Dang, Max Hamaker, Peng Sun, et al.
Archives of Biochemistry and Biophysics|June 11, 2002
Evidence for involvement of calpain in c-Myc proteolysis in vivoGeorge W Small, Teh-Ying Chou, Chi V Dang, et al.
Nature Reviews. Drug Discovery|December 4, 2021
Targeting cancer metabolism in the era of precision oncologyZachary E Stine, Zachary T Schug, Joseph M Salvino, et al.
The Journal of Biological Chemistry|January 20, 2007
The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidaseYoan Konto Ghiorghi, Karen I Zeller, Chi V Dang, et al.
Nature Communications|March 24, 2017
Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBαBrian J Altman, Annie L Hsieh, Arvin M Gouw, et al.
Molecular Cancer Therapeutics|September 6, 2018
Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for CancerLin Zhang, Dan Peng, Anil K Sood, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2003
Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune responseDanielle B Ulanet, Michael Torbenson, Chi V Dang, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2006
MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2Debabrita Deb-Basu, Asa Karlsson, Qing Li, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Cell Metabolism|March 7, 2006
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxiaJung-whan Kim, Irina Tchernyshyov, Gregg L Semenza, et al.
Trends in Cancer|September 5, 2021
Tilting MYC toward cancer cell deathColleen T Harrington, Elena Sotillo, Chi V Dang, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 9, 2011
Therapeutic targeting of cancer cell metabolismChi V Dang, Max Hamaker, Peng Sun, et al.
Archives of Biochemistry and Biophysics|June 11, 2002
Evidence for involvement of calpain in c-Myc proteolysis in vivoGeorge W Small, Teh-Ying Chou, Chi V Dang, et al.
Nature Reviews. Drug Discovery|December 4, 2021
Targeting cancer metabolism in the era of precision oncologyZachary E Stine, Zachary T Schug, Joseph M Salvino, et al.
The Journal of Biological Chemistry|January 20, 2007
The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidaseYoan Konto Ghiorghi, Karen I Zeller, Chi V Dang, et al.
Nature Communications|March 24, 2017
Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBαBrian J Altman, Annie L Hsieh, Arvin M Gouw, et al.
Molecular Cancer Therapeutics|September 6, 2018
Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for CancerLin Zhang, Dan Peng, Anil K Sood, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2003
Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune responseDanielle B Ulanet, Michael Torbenson, Chi V Dang, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2006
MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2Debabrita Deb-Basu, Asa Karlsson, Qing Li, et al.
Pageof 20